These data support the notion that over-expression of miR-130a/301a/454 leads to Smad4 down-regulation, thus inhibiting TGF-β signaling-mediated cell growth suppression, which contributes to the development of colon cancer. This evidence concerns the gene SMAD4 and colonic neoplasm.